🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 7 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/11/1996 | 45,38 | 45,38 | 44,45 | 45,15 | -0,52% | 2,06% | 45.525 |
| 27/11/1996 | 45,85 | 45,85 | 44,45 | 45,38 | -1,02% | 3,06% | 92.173 |
| 26/11/1996 | 44,45 | 45,85 | 43,51 | 45,85 | +6,52% | 5,26% | 140.503 |
| 25/11/1996 | 43,98 | 44,45 | 42,11 | 43,04 | +2,22% | 5,32% | 86.749 |
| 22/11/1996 | 43,04 | 44,92 | 42,11 | 42,11 | -2,17% | 6,52% | 67.299 |
| 21/11/1996 | 44,92 | 44,92 | 43,04 | 43,04 | -2,13% | 4,17% | 27.946 |
| 20/11/1996 | 43,98 | 45,85 | 43,98 | 43,98 | -1,05% | 4,26% | 37.190 |
| 19/11/1996 | 43,98 | 44,92 | 43,04 | 44,45 | +1,06% | 4,26% | 49.132 |
| 18/11/1996 | 43,98 | 44,45 | 43,98 | 43,98 | -1,05% | 1,06% | 19.904 |
| 15/11/1996 | 45,85 | 45,85 | 43,98 | 44,45 | -1,04% | 4,08% | 31.339 |
| 14/11/1996 | 46,32 | 46,32 | 44,92 | 44,92 | -2,04% | 3,03% | 33.022 |
| 13/11/1996 | 45,85 | 46,32 | 44,92 | 45,85 | -1,01% | 3,06% | 51.002 |
| 12/11/1996 | 46,32 | 47,72 | 46,32 | 46,32 | -1,00% | 3,03% | 50.414 |
| 11/11/1996 | 47,26 | 47,26 | 46,32 | 46,79 | -0,99% | 1,98% | 23.671 |
| 08/11/1996 | 47,26 | 47,26 | 46,32 | 47,26 | +2,02% | 1,98% | 25.461 |
| 07/11/1996 | 47,26 | 47,26 | 46,32 | 46,32 | +0,00% | 1,98% | 53.674 |
| 06/11/1996 | 47,26 | 47,26 | 46,32 | 46,32 | -1,98% | 1,98% | 21.961 |
| 05/11/1996 | 47,26 | 47,26 | 46,32 | 47,26 | +0,00% | 1,98% | 36.148 |
| 04/11/1996 | 46,32 | 47,26 | 46,32 | 47,26 | +1,00% | 2,02% | 46.487 |
| 01/11/1996 | 46,32 | 47,26 | 45,85 | 46,79 | +1,01% | 3,03% | 34.384 |
| 31/10/1996 | 46,32 | 47,26 | 46,32 | 46,32 | +0,00% | 2,02% | 27.171 |
| 30/10/1996 | 47,72 | 47,72 | 45,85 | 46,32 | -1,00% | 3,92% | 30.003 |
| 29/10/1996 | 47,72 | 47,72 | 45,85 | 46,79 | -0,99% | 3,92% | 60.380 |
| 28/10/1996 | 46,32 | 47,72 | 45,85 | 47,26 | +1,00% | 4,04% | 101.016 |
| 25/10/1996 | 44,92 | 47,72 | 44,92 | 46,79 | -6,98% | 6,25% | 323.379 |
| 24/10/1996 | 50,06 | 51,47 | 50,06 | 50,30 | -0,46% | 2,80% | 20.705 |
| 23/10/1996 | 50,53 | 52,40 | 49,59 | 50,53 | +0,00% | 5,56% | 26.129 |
| 22/10/1996 | 51,00 | 52,40 | 50,53 | 50,53 | -2,70% | 3,67% | 21.026 |
| 21/10/1996 | 51,47 | 52,40 | 50,53 | 51,93 | -0,89% | 3,64% | 44.083 |
| 18/10/1996 | 51,93 | 52,40 | 51,47 | 52,40 | +0,90% | 1,80% | 27.251 |